CCL Products (India) Limited has allotted 6,785 equity shares of face value Rs. 2/- each pursuant to the exercise of options granted under the "CCL Employee Stock Option Scheme – 2022". The exercise price per share was Rs. 2/-, with a premium of Nil. The shares were issued on 11-09-2026.
The total number of issued shares remains unchanged at 13,35,27,920, and the total issued share capital remains unchanged at Rs. 26,70,55,840/- (divided into 13,35,27,920 equity shares of Rs. 2/- each). The company confirmed that the newly allotted shares shall rank pari-passu with the existing shares of the Company.
The shares were issued in demat form with the ISIN INE421D01022. The distinctive numbers for the allotted shares range from 133335340 to 133342124. There are no lock-in restrictions applicable to these shares, and they are identical in all respects to the existing shares. No listing fees are payable for this issuance.
Compliance Details
The issuance is in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, specifically pursuant to Regulation 10.
The scheme under which the shares were issued is titled "CCL Employee Stock Option Scheme - 2022". The company had previously filed statements for this scheme with the stock exchanges:
- For 4,00,000 shares: Filed with NSE (Ref: NSE/LIST/32675) on 23.09.2022 and with BSE (Ref: DCS/IPO/MJ/ESOPIP/2501/2022-23) on 22.09.2022.
- For 1,00,000 shares: Filed with NSE (Ref: NSE/LIST/39980) on 09.02.2024 and with BSE (Ref: DCS/IPO/JP/ESOPIP/3107/2023-24) on 09.02.2024.
The letter was signed by Sridevi Dasari, Company Secretary & Compliance Officer, on September 11, 2026.